NY-VIACOMCBS
20.10.2020 14:47:11 CEST | Business Wire | Press release
ViacomCBS Networks International (VCNI), a division of ViacomCBS Inc. (NASDAQ: VIAC), has today confirmed the departure of one of its longest serving executives, Pierluigi Gazzolo, who will step down from his role as President, Streaming and Studios for VCNI at the end of this month to focus on other interests.
During Gazzolo’s tenure as President of Streaming and Studios for VCNI, he successfully established the content proposition, team and go to market strategy for the international launch of Paramount+ and expanded the roadmap for Pluto TV internationally.
VCNI Streaming Leadership
Reporting to David Lynn, President and CEO of VCNI, and working closely with Tom Ryan, President & CEO of ViacomCBS Streaming, Kelly Day, Chief Operating Officer of VCNI, will take over leadership of the division’s streaming business as President of Streaming and COO of VCNI. In this new role, Day will have oversight of the international roll-out of Paramount+, a new premium SVOD service due to launch in 2021 across Australia, Latin America, and the Nordics; as well as the ongoing expansion of Pluto TV, following its successful launch in Latin America.
Regarding Day’s expanded remit, Lynn added, “We are in the fortunate position of going from strength to strength with this transition. With a truly global streaming organization, it’s a pivotal moment in the evolution of our streaming strategy, with the expansion of Paramount+ and Pluto TV, both of which are critical to our future growth. Kelly has an enviable track record of launching and growing streaming businesses and has added a layer of extraordinary digital expertise to our management team in a short space of time. Now, also, working closely with Tom Ryan, I’m confident Kelly will accelerate our transition to becoming a more digitally-led business, while seizing our global streaming opportunity.”
ViacomCBS International Studios Leadership
ViacomCBS Studios International (VIS) will supply original content to the new Paramount+ service in some markets, while continuing to supply scripted, comedy and reality series to VCNI’s free and pay TV networks as well as third party streamers and broadcasters.
Also, reporting to Lynn, JC Acosta, who oversees VCNI’s operations in Latin America and Canada as President, VCN Americas, will take on additional responsibility as President, ViacomCBS International Studios.
Lynn added, “One of our biggest achievements in recent years has been the formation and expansion of VIS, which really couldn’t have happened without Pier’s vision. In the past year, under Pier’s leadership he doubled the global development slate, setting VCNI up for continued global success in the studios arena.”
“Now with JC’s expertise in production and development, coupled with his drive and dedication its incredibly reassuring that JC will take over leadership of VIS,” said Lynn. “Given JC’s intimate understanding of our Studios business, his connections and his knowledge of the international content market, we couldn’t be better positioned for continued growth.”
Gazzolo’s Tenure
Paying tribute to Gazzolo, Lynn said, “While he will hate to be labelled as a veteran, there’s no better word to describe someone who has dedicated so much of his career to our company and who has benefited it so much with his wisdom and experience. He’s a brilliant all-rounder who has played in many positions for our team, but always with the same outstanding results. It’s typical of Pier’s commitment that he’s stayed to oversee a seamless handover to Kelly and JC, even though he’s been signaling his interest in pursuing his own projects for some time. I can’t thank him enough for his contribution to our business over many years. I know everyone at VCNI will join me in genuinely wishing him well in his future endeavors.”
Gazzolo commented, “I’ve grown up with this amazing company. From MTV Latino, to MTV Networks to Viacom International Media Networks to post merger ViacomCBS Networks International. I’ve been honored to grow and evolve with ViacomCBS, and I’m immensely grateful to have worked across so many regions and divisions at the most dynamic media company in the world. I have benefited tremendously from having worked with unparalleled leaders and mentors, throughout my tenure, but especially in the latest chapter of my term. Most importantly I’ve created wonderful close friendships in my 27 years with the company – and those will continue long after I leave the building.”
About Pierluigi Gazzolo
Prior to taking up his current role as President, Streaming and Studios in November 2019, Pierluigi Gazzolo was President, Americas for Viacom International Media Networks, which was renamed as VCNI after the ViacomCBS merger in December last year.
Based in Miami, he oversaw a marked expansion of the company’s operations across Spanish-speaking Latin America and Brazil, spearheaded by two key acquisitions – ownership of Argentina’s leading free-to-air broadcaster, Telefe (2016), and a majority stake in Brazilian comedy producer, Porta dos Fundos (2017). Combining Telefe’s studios business and Porta dos Fundos with VIMN’s existing production activities in the region, Gazzolo formed VIS and secured its first sales to both Netflix and Amazon Prime, as well as a host of other deals with broadcasters and streamers across the region. Under his leadership, VIS has expanded its production activities in the UK, Europe, and Asia.
At the same time as leading the company’s operations in Latin America, Gazzolo continued to lead Nickelodeon internationally, giving him oversight of this critical brand in all markets outside the U.S. In this role, he oversaw an increase in international supply to Nickelodeon’s global content pipeline with locally developed shows being remade for global distribution, including Talia in the Kitchen and Every Witch Way.
Previously, Gazzolo was Chief Operating Officer for VIMN (2011 to 2014) and its predecessor MTV Networks International (2009 to 2011), reporting in both roles to Bob Bakish, who is now CEO, ViacomCBS Inc. Before 2009, he held several different roles with the company including serving as President of MTV Networks Latin America.
ViacomCBS Networks International:
ViacomCBS Networks International, a unit of ViacomCBS Inc. (NASDAQ: VIAC), comprises many of the world’s most iconic entertainment brands, including Network 10, Channel 5, Telefe, Viacom 18, ViacomCBS International Studios, Nickelodeon, MTV, Comedy Central, BET, Paramount Network and Pluto TV. In addition to offering innovative streaming services and digital video products, ViacomCBS Networks International provides powerful capabilities in production, distribution and advertising solutions for partners on five continents and across more than 180 countries.
VIAC-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005683/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
